4/16
08:20 am
mnpr
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings [Yahoo! Finance]
Low
Report
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings [Yahoo! Finance]
4/16
08:00 am
mnpr
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings
Low
Report
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings
4/11
08:06 am
mnpr
Monopar Therapeutics Inc. (NASDAQ: MNPR) was upgraded by analysts at Jonestrading from a "hold" rating to a "buy" rating. They now have a $2.00 price target on the stock.
High
Report
Monopar Therapeutics Inc. (NASDAQ: MNPR) was upgraded by analysts at Jonestrading from a "hold" rating to a "buy" rating. They now have a $2.00 price target on the stock.
4/10
08:13 am
mnpr
Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients [Yahoo! Finance]
Medium
Report
Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients [Yahoo! Finance]
4/10
08:00 am
mnpr
Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients
High
Report
Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients
4/4
11:39 am
mnpr
Monopar Therapeutics (MNPR) Could Find a Support Soon, Here's Why You Should Buy the Stock Now [Yahoo! Finance]
Low
Report
Monopar Therapeutics (MNPR) Could Find a Support Soon, Here's Why You Should Buy the Stock Now [Yahoo! Finance]
4/3
01:21 pm
mnpr
All You Need to Know About Monopar Therapeutics (MNPR) Rating Upgrade to Buy [Yahoo! Finance]
Medium
Report
All You Need to Know About Monopar Therapeutics (MNPR) Rating Upgrade to Buy [Yahoo! Finance]
3/28
07:09 am
mnpr
Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments [Yahoo! Finance]
Medium
Report
Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments [Yahoo! Finance]
3/28
07:00 am
mnpr
Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments
Medium
Report
Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments
3/5
07:11 am
mnpr
Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program [Yahoo! Finance]
Medium
Report
Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program [Yahoo! Finance]
3/5
07:00 am
mnpr
Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program
Medium
Report
Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program
2/27
07:12 am
mnpr
Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial [Yahoo! Finance]
Medium
Report
Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial [Yahoo! Finance]
2/27
07:00 am
mnpr
Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial
Medium
Report
Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial
2/27
05:55 am
mnpr
Here's Why We're Watching Monopar Therapeutics' (NASDAQ:MNPR) Cash Burn Situation [Yahoo! Finance]
Medium
Report
Here's Why We're Watching Monopar Therapeutics' (NASDAQ:MNPR) Cash Burn Situation [Yahoo! Finance]
2/23
12:43 pm
mnpr
CPOP, PMEC and ARIZ among mid-day movers [Seeking Alpha]
Low
Report
CPOP, PMEC and ARIZ among mid-day movers [Seeking Alpha]
2/22
07:06 am
mnpr
Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers [Yahoo! Finance]
High
Report
Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers [Yahoo! Finance]
2/22
07:00 am
mnpr
Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers
High
Report
Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers
2/20
08:12 am
mnpr
Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers [Yahoo! Finance]
High
Report
Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers [Yahoo! Finance]
2/20
08:00 am
mnpr
Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers
High
Report
Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers